NOT:ETR
Novartis AG
145,56 €
arrow_upward
+1,66%(+2,38) 1 p
30. okt, 17:35:39 GMT +1 · EUR
search
Kõik sümbolid
| Sümbol | Hind | Muutus | % muutus |
|---|
insights_autoÜksuse NOT põhistatistika genereerimine…
Ava
145,32 €
Kõrge
146,80 €
Madal
144,76 €
Turu kapit.
326,00 mld
Keskm. maht
5,36 tuh
Maht
6,31 tuh
52 näd kõrgeim
146,80 €
52 näd madalaim
105,60 €
Töötajate arv
75 tuh
Ava
145,32 €
Kõrge
146,80 €
Madal
144,76 €
Turu kapit.
326,00 mld
Keskm. maht
5,36 tuh
Maht
6,31 tuh
52 näd kõrgeim
146,80 €
52 näd madalaim
105,60 €
Töötajate arv
75 tuh
Uudised
Veebiallikatest ja uudistepartneritelt
Yahoo Finance
·
1 päeva eest
All You Need to Know About Novartis (NVS) Rating Upgrade to Buy
BioPharma Dive
·
2 päeva eest
Earnings roundup: Lilly’s unwavering momentum, Novartis’ rebound and GSK’s waiting game
Profiil
Novartis AG is a Swiss multinational pharmaceutical corporation based in Basel, Switzerland. Novartis is one of the largest pharmaceutical companies in the world and was the eighth largest by revenue in 2024.
Novartis manufactures the drugs clozapine, diclofenac, carbamazepine, valsartan, imatinib mesylate, cyclosporine, letrozole, methylphenidate, terbinafine, deferasirox, and others.
Novartis was formed in 1996 by the merger of Ciba-Geigy and Sandoz. It was considered the largest corporate merger in history during that time. The pharmaceutical and agrochemical divisions of both companies formed Novartis as an independent entity. The name Novartis was based on the Latin terms, novae artes.
After the merger, other Ciba-Geigy and Sandoz businesses were sold, or, like Ciba Specialty Chemicals, spun off as independent companies. The Sandoz brand disappeared for three years, but was revived in 2003 when Novartis consolidated its generic drugs businesses into a single subsidiary and named it Sandoz. Wikipedia
Teave üksuse Novartis AG kohta
TegevjuhtVasant Narasimhan
Töötajad75,3 tuh
Asutatud7. märts 1996
PeakontoridBasel, Basel, Šveits
Sektor-
Veebisaitnovartis.com